PHARMA NORD EXPORT ApS: Financial statements 2019
CVR: 70996510
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
PHARMA NORD EXPORT ApS (CVR 70996510) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,953,365 and a net result of DKK -582,561 compared with DKK 4,272,843 the year before. That is a decrease of 5.9% compared with the year before. Equity in the 2019 report amounted to DKK 73,089,166. The solvency ratio was 77.6%.
- Gross Profit
- DKK 1,953,365
- Profit/Loss
- DKK -582,561
- Equity
- DKK 73,089,166
- Total Assets
- DKK 94,234,078
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 2 mio. | -583 t. | 73.1 mio. | - |
| 2018 | - | 2.1 mio. | 4.3 mio. | 69.8 mio. | - |
| 2017 | - | 1.9 mio. | 3.5 mio. | 65.5 mio. | - |
| 2016 | - | 2.2 mio. | 2.7 mio. | 62 mio. | - |
| 2015 | - | 2.3 mio. | 3.2 mio. | 59.3 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
PHARMA NORD EXPORT ApS has published its annual report for 2018. Gross profit came to DKK 2,076,384, and the net result was DKK 4,272,843.
About PHARMA NORD EXPORT ApS
PHARMA NORD EXPORT ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1982. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named TRAUDE SCHNEIDER ASTROFAKTA-DANMARK ApS. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO II ApS and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK 1,575,000 and a net result of DKK 11,516,000 compared with DKK 6,889,205 the year before. Equity in the 2025 report amounted to DKK 46,928,000.